T-ALL
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| SENL101 Autologous T Cell Injection in Adults With Relapsed or Refractory CD7+ Hematolymphoid Malignancies (NCT05398614) | Hebei Senlang Biotechnology Inc., Ltd. | 2022-05-01 |
| CD7 CAR-T in the Treatment of CD7 Positive Refractory Relapsed Acute Leukemia (NCT04785833) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2021-03-04 |
| Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies (NCT03422679) | Cellestia Biotech AG | 2017-12-05 |
Track T-ALL automatically
Every clearance here is in the API, with alerts when new ones post.